I‐Fen Chen
Impact in
- Drug Discovery top 10%
-
- Hydrogels: synthesis, properties, applications
- Curcumin's Biomedical Applications
Papers in
-
- Nanoparticle-Based Drug Delivery 1
- Collagen: Extraction and Characterization 1
- Oncology 2
- Cancer-related Molecular Pathways 1
- Co-authors
- Ming‐Feng Hou (3 shared papers)Fu Ou‐Yang (3 shared papers)Shyh‐Ming Kuo (5 shared papers)Shao‐Chun Wang (2 shared papers)Jen‐Yu Hung (1 shared paper)Gabriel N. Hortobágyi (1 shared paper)Mien‐Chie Hung (1 shared paper)Shwu‐Jen Chang (3 shared papers)
- Journals
- Molecules (2 papers)Molecular Cancer Therapeutics (1 paper)Journal of Biomedical Materials Research Part B Applied Biomaterials (1 paper)Materials Letters (1 paper)Antioxidants (1 paper)
- Partner nations
- TaiwanChinaUnited States
In The Last Decade
I‐Fen Chen
11 papers receiving 366 citations
Peers
Comparison fields: 5 of 59
- Drug Discovery 6
- Molecular Medicine 27
- Biomaterials 40
- Pharmaceutical Science 20
- Cancer Research 35
Countries citing papers authored by I‐Fen Chen
This map shows the geographic impact of I‐Fen Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I‐Fen Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I‐Fen Chen more than expected).
Fields of papers citing papers by I‐Fen Chen
This network shows the impact of papers produced by I‐Fen Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I‐Fen Chen. The network helps show where I‐Fen Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside I‐Fen Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 117 | |
| 2 | 2006 | 52 | |
| 3 | 2015 | 47 | |
| 4 | 2013 | 34 | |
| 5 | 2010 | 31 | |
| 6 | 2018 | 27 | |
| 7 | 2014 | 17 | |
| 8 | 2018 | 17 | |
| 9 | 2010 | 13 | |
| 10 | 2017 | 10 | |
| 11 | 2023 | 7 |
About I‐Fen Chen
I‐Fen Chen is a scholar working on Biomaterials, Oncology, Molecular Medicine, Hepatology and Pharmacology, having authored 11 papers that have together received 372 indexed citations. Recurring topics across this work include Liver physiology and pathology (1 paper), Nanoparticle-Based Drug Delivery (1 paper), Liver Disease Diagnosis and Treatment (1 paper), Cancer-related Molecular Pathways (1 paper), Bone Tissue Engineering Materials (1 paper), Natural Antidiabetic Agents Studies (1 paper), Osteoarthritis Treatment and Mechanisms (1 paper) and Collagen: Extraction and Characterization (1 paper). The work is most often cited by research in Drug Discovery (6 citations), Molecular Medicine (27 citations), Biomaterials (40 citations), Pharmaceutical Science (20 citations) and Cancer Research (35 citations). I‐Fen Chen has collaborated with scholars based in Taiwan, China and United States. Frequent co-authors include Ming‐Feng Hou, Fu Ou‐Yang, Shyh‐Ming Kuo, Shao‐Chun Wang, Jen‐Yu Hung, Gabriel N. Hortobágyi, Mien‐Chie Hung, Shwu‐Jen Chang, Shyng‐Shiou F. Yuan and Chun‐Hsu Yao. Their work appears in journals such as Molecules, Molecular Cancer Therapeutics, Journal of Biomedical Materials Research Part B Applied Biomaterials, Materials Letters and Antioxidants.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.